Note: The fiscal year start dates of major companies differ from the calendar year, so there may be inconsistencies between fiscal quarters, fiscal years, and the calendar year.Companies may announce their performance on a quarterly or semi-annual basis.

Medtronic Releases First Quarter Earnings for Fiscal Year Ending July 25, 2025.Quarterly net sales were US$8.578 billion, compared to US$7.915 billion in the same period last year.Quarterly operating profit was $1.445 billion, compared to $1.278 billion in the same period last year. Quarterly net profit attributable to the company was $1.04 billion, compared to $1.042 billion in the same period last year.

Johnson & Johnsonn) Announced the financial results for the second quarter of 2025. Quarterly sales reached 23.743 billion USD, compared to 22.447 billion USD in the same period last year, representing a year-on-year increase of 5.8%. Quarterly net profit was 5.537 billion USD, compared to 4.686 billion USD in the same period last year.billion USD, representing a year-over-year increase of 18.2%. The adjusted net profit was 6.699 billion USD, compared to 6.84 billion USD in the same period last year, marking a year-over-year decrease of 2.1%. Among this, the sales revenue from the innovative pharmaceuticals business reached 15.201 billion USD, reflecting a year-over-year growth of 4.9%.Medical device business sales reached 8.541 billion US dollars, increasing by 7.3% year-on-year.

Abbott Announces Second Quarter 2025 ResultsNet sales for the quarter were $11.142 billion, compared to $10.377 billion in the same period last year, representing a 7.4% year-over-year increase.Quarterly operating profit was $2.052 billion, compared to $1.669 billion in the same period last year, representing a 23% year-over-year increase. Quarterly net profit was $1.779 billion, compared to $1.302 billion in the same period last year, marking a 36.7% year-over-year increase. Among these figures, sales from the nutrition business reached $2.212 billion, sales from the diagnostics business were $2.173 billion, sales from the pharmaceuticals business amounted to $1.383 billion, and sales from the medical devices business totaled $5.369 billion.

Siemens Healthineers Releases Third Quarter Results for Fiscal Year Ending June 30, 2025.Quarterly revenue was 56.62 billion euros (approximately 65.74 billion US dollars), compared to 54.23 billion euros in the same period last year, representing a year-on-year increase of 4.4%.EBIT profit adjusted for the quarter was 953 million euros, compared to 825 million euros in the same period last year, representing a 15% year-over-year increase. Quarterly net profit reached 556 million euros, up from 472 million euros in the same period last year, marking an 18% year-over-year growth.

Stryker Releases Financial Results for the Second Quarter of 2025.Net sales for the quarter were $6.022 billion, compared to $5.422 billion in the same period last year, representing an increase of 11.1%.Quarterly operating profit was $1.113 billion, compared to $1.051 billion in the same period last year, representing a 5.9% year-over-year increase. Quarterly net profit was $884 million, compared to $825 million in the same period last year, reflecting a 7.2% year-over-year growth.

Fresenius Medical Care Announces Q2 2025 Results: Total Revenue of €4.792 Billion (~$5.563 Billion), Operating Profit at €425 Million, Net Income at €225 Million

BD Reports Third Quarter Fiscal 2025 Results Ended June 30, 2025. Quarterly revenue was $5.509 billion, compared to $4.99 billion in the same period last year, representing a year-over-year increase of 10.4%. Quarterly operating profit was $882 million, compared to $602 million in the same period last year. Quarterly net profit was $575 million, compared to $487 million in the same period last year.

Thermo Fisher Scientific Announces Q2 2025 Financial Results. Quarterly revenue reached $10.855 billion, compared to $10.541 billion in the same period last year. Quarterly operating profit was $1.834 billion, versus $1.82 billion in the prior-year period. Net income attributable to the company for the quarter was $1.617 billion, compared to $1.548 billion in the same quarter last year. Specifically, Life Sciences segment revenue was $2.499 billion, Laboratory Products and Biopharma Services revenue was $5.995 billion, Specialty Diagnostics revenue was $1.134 billion, and Analytical Instruments revenue was $1.728 billion.

Danaher Announces Q2 2025 Financial Results. Quarterly revenue was $5.936 billion, compared to $5.743 billion in the same period last year. Quarterly operating profit was $760 million, compared to $1.168 billion last year. Quarterly net profit was $555 million, compared to $907 million last year.

Philips Announces Q2 2025 Results. Quarterly sales reached €4.338 billion (approximately $5.036 billion), compared to €4.462 billion in the same period last year. Quarterly operating profit was €400 million, down from €816 million in the previous year. Net profit for the quarter was €240 million, compared to €452 million in the same period last year.

Boston Scientific Announces Q2 2025 Financial Results. Net sales for the quarter were $5.061 billion, compared to $4.12 billion in the same period last year. Operating profit for the quarter was $819 million, compared to $520 million in the same period last year. Net income attributable to common shareholders for the quarter was $797 million, compared to $324 million in the same period last year.

GE HealthCare Reports Q2 2025 Earnings. Total revenue for the quarter was $5.007 billion, compared to $4.839 billion in the same period last year. Operating profit for the quarter was $654 million, compared to $608 million last year. Net profit attributable to the company for the quarter was $486 million, compared to $428 million in the same period last year.

Roche Announces Financial Results for the First Half of 2025. During this period, the group's sales revenue reached 30.944 billion Swiss francs, compared to 29.848 billion Swiss francs in the same period last year. Operating profit for the period was 12.01 billion Swiss francs, compared to 11.293 billion Swiss francs in the same period last year. Net profit under International Financial Reporting Standards (IFRS) for the period was 7.832 billion Swiss francs, compared to 6.697 billion Swiss francs in the same period last year. Of this, pharmaceutical business sales revenue was 23.985 billion Swiss francs, with an operating profit of 12.522 billion Swiss francs. Diagnostic business sales revenue was 6.959 billion Swiss francs (approximately 8.6 billion U.S. dollars), with an operating profit of 1.25 billion Swiss francs.

Henry Schein Announces Q2 2025 Results. Net sales for the quarter were $3.24 billion, compared to $3.136 billion in the same period last year. Operating profit for the quarter was $151 million, compared to $159 million in the same period last year. Net profit attributable to the company for the quarter was $86 million, compared to $104 million in the same period last year.

Cardinal Health Reports Fourth Quarter and Fiscal Year 2025 Results Ended June 30, 2025. Fourth quarter revenue was $60.159 billion, operating profit was $428 million, and net income attributable to the company was $239 million. Fiscal year revenue was $222.6 billion, operating profit was $2.275 billion, and net income attributable to the company was $1.561 billion. Among these, the medical products and distribution business reported fourth quarter revenue of $31.99 billion and profit of $70 million; full-year revenue was $126.36 billion and profit was $135 million.

Baxter International Announces Q2 2025 Results. Net sales for the quarter were $2.81 billion, compared to $2.694 billion in the same period last year, representing a 4% year-over-year increase. Operating profit for the quarter was $191 million, up from $179 million in the same period last year, a 7% increase. Net income attributable to the company for the quarter was $91 million, compared to a net loss of $314 million in the same period last year.

Intuitive Surgical Announces Q2 2025 Results. Total revenue for the quarter was $2.44 billion, compared to $2.01 billion in the same period last year. Operating profit for the quarter was $743 million, compared to $567 million in the same period last year. Net profit attributable to the company for the quarter was $658 million, compared to $527 million in the same period last year.

Solventum Announces Q2 2025 Results. Total net sales for the quarter were $2.161 billion, compared to $2.081 billion in the same period last year. Operating profit for the quarter was $214 million, compared to $244 million in the same period last year. Net profit for the quarter was $90 million, compared to $89 million in the same period last year.

Zimmer Biomet Holdings Reports Q2 2025 Results. Net sales for the quarter were $2.077 billion, compared to $1.942 billion in the same period last year. Operating profit for the quarter was $300 million, compared to $351 million in the same period last year. Net income attributable to the company for the quarter was $153 million, compared to $243 million in the same period last year.

Terumo Reports First Quarter Results for the Period Ended June 30, 2025. Quarterly revenue reached 259.965 billion yen (approximately $1.751 billion USD), compared to 258.194 billion yen in the same period last year. Operating profit was 55.885 billion yen, up 25.2% from 44.64 billion yen in the previous year. Net profit attributable to owners of the parent company was 41.843 billion yen, an increase of 23.5% from 33.891 billion yen in the prior-year period.

Fujifilm Holdings announced its first-quarter financial results for the period ending June 30, 2025. Quarterly revenue reached 749.5 billion yen, compared to 749.0 billion yen in the same period last year. Operating profit was 75.3 billion yen, an increase of 13.1% from 62.2 billion yen in the previous year. Net income attributable to the company was 53.8 billion yen, compared to 60.7 billion yen in the same period last year. Across all business segments,Medical and health business revenue was 228.5 billion yen (approximately 1.539 billion US dollars), a year-on-year decrease of 6.7%.Revenue from the electronic materials business was 102.1 billion yen, a year-on-year decrease of 1%. Revenue from the imaging business was 145.3 billion yen, a year-on-year increase of 14.6%. Revenue from the commercial innovation business was 273.6 billion yen, a year-on-year decrease of 6.5%.

Olympus (OLYMPUS) Announces First Quarter Results for Fiscal Year Ending June 30, 2025. Quarterly revenue was 206.512 billion yen (approximately 1.391 billion US dollars), compared to 234.821 billion yen in the same period last year, representing a year-on-year decrease of 12.1%. Operating profit was 16.597 billion yen, compared to 27.477 billion yen in the same period last year, marking a year-on-year decrease of 39.6%. Net profit attributable to owners of the parent company was 8.991 billion yen, compared to 14.583 billion yen in the same period last year, indicating a year-on-year decrease of 38.3%.

Canon Group (Canon) Announces Q2 2025 Results. Net sales for the quarter were 1,140.171 billion yen, compared to 1,167.786 billion yen in the same period last year. Operating profit for the quarter was 117.791 billion yen, compared to 118.391 billion yen in the same period last year. Net profit attributable to the company for the quarter was 83.673 billion yen, compared to 89.857 billion yen in the same period last year. Of this, net sales in the printing business field were 610.612 billion yen.Net sales in the medical business field were 141.959 billion yen (approximately 9.56 billion US dollars), and net sales in the imaging business field were 260.668 billion yen.Net sales in the industrial business field amounted to 92.372 billion yen.

EssilorLuxottica Reports First Half 2025 Financial Results. Adjusted revenue for the period was 14.024 billion euros, compared to 13.29 billion euros in the same period last year. Adjusted operating profit was 2.532 billion euros, compared to 2.431 billion euros last year. Adjusted group net profit was 1.799 billion euros, compared to 1.746 billion euros last year. Revenue from the Professional Solutions business was 6.565 billion euros (approximately 7.62 billion U.S. dollars), compared to 6.414 billion euros in the same period last year. Consumer business revenue was 7.459 billion euros, compared to 6.876 billion euros last year.

Alcon Announces Q2 2025 Results. Net sales for the quarter were $2.577 billion, compared to $2.482 billion in the same period last year. Operating profit for the quarter was $247 million, compared to $318 million in the same period last year. Net profit attributable to shareholders for the quarter was $176 million, compared to $223 million in the same period last year.

Bausch+Lomb Reports Q2 2025 Results. Revenue for the quarter was $1.278 billion, compared to $1.216 billion in the same period last year. Operating loss for the quarter was $11 million, compared to an operating loss of $94 million in the same period last year. Net loss attributable to the company for the quarter was $62 million, compared to a net loss of $151 million in the same period last year.